Clinical Trials Browser

Phase 1/2 × INDUSTRY × gedatolisib × Clear all

NCT06190899 2026-04-13

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Recruiting

Genital Diseases, Male, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT01937715 2016-08-18

A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer

Phase 1/2 Terminated

18 enrolled 23 charts

Gastrointestinal

Colorectal Neoplasms